Who is sponsoring NCT04669314?

NCT04669314 is sponsored by Ankara University.

What drugs are being tested in NCT04669314?

Interventions in NCT04669314: Liver resection or enucleation for liver hemangioma.

What condition does NCT04669314 study?

NCT04669314 studies Hemangioma Liver.

Is NCT04669314 still recruiting?

NCT04669314 is currently completed. Last updated 16 December 2020.

Last reviewed 2020-12-16 · How we verify

NCT04669314

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Approach in Liver Hemangiomas

Completed Last updated 16 December 2020

What this trial tests

trial testing Liver resection or enucleation for liver hemangioma in Hemangioma Liver in 69 participants. Completed in 30 October 2020.

Timeline

1 October 2020

Primary endpoint
20 October 2020

30 October 2020

Quick facts

Lead sponsor	Ankara University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	69
Start date	1 October 2020
Primary completion	20 October 2020
Estimated completion	30 October 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Liver resection or enucleation for liver hemangioma

Conditions studied

Hemangioma Liver — all drugs for Hemangioma Liver →

Sponsor

Ankara University

Who can join

18 and older, any sex, with Hemangioma Liver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Operations performed for liver hemangioma between January 2017 and December 2018 will be retrospectively analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04669314 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 16 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04669314.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing